Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: J Urol. 2010 Sep;184(3):859–864. doi: 10.1016/j.juro.2010.05.041

Table 2.

Surgical and pathologic outcomes of study patients.

Study patients Historic control*

Lap radical
(n=12)
Lap partial
(n=8)
Lap radical
(n=55)
Lap partial
(n=97)
Surgical Operative time (min) 252 (159-376) 211 (170-275) 222 (100-605) 197 (95-316)
Parameters EBL (ml) 430 (20-1400) 384 (100-700) 464 (5-7000) 258
No. patients transfused 0 0 6 (11%) 3 (3%)
Warm ischemia (min) Not applicable 35 (13-51) Not applicable 20 (8-50)**
Hospital stay (days) 2.0 (1-4) 1.9 (1-6) 2.5 (1-20) 1.7 (1-11)
Postop CrCl 71 (46-94) 89 (43-171) 69 (27-138) 85 (18-147)
Pathology Pathologic T category
 pT1a 0 5 (63%) 7 (13%) 67 (69%)
 pT1b 1 (8%) 2 (25%) 14 (26%) 6 (6%)
 pT2 5 (42%) 0 12 (22%) 0
 pT3a 3 (25%) 1 (13%) 10 (18%) 5 (5%)
 pT3b 1 (8%) 0 3 (5%) 0
 pT4 2 (16%) 0 4 (7%) 0
Clinical N category
 pNx 0 6 (75%) 9 (16%) 77 (79%)
 pN0 10 (83%) 2 (25%) 36 (65%) 0
 pN1 0 0 0 0
 pN2 2 (17%) 0 5 (9%) 1 (1%)
Positive margins 0 1 (13%) 4 (7%) 2 (2%)
No. lymph nodes
 examined
13.5 (3-24) Not applicable 14 (3-24) Not applicable
*

Surgeries performed by the same surgeon at the same institution during the study period

**

p-value comparing study patients and historic control patients who underwent lap partial (only p-value<0.05 are noted):

Warm ischemia <0.001

Abbreviations: Lap radical, laparoscopic radical nephrectomy, Lap partial, laparoscopic partial nephrectomy, EBL, estimated blood loss, CrCl, creatinine clearance